Side-by-side financials for EDIT and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EDIT | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $40.52M | - |
| Net income (latest FY) | -$160.06M | - |
| Net margin | -395.0% | - |
| SEC filings | 693 | 548 |
Full pages: Editas Medicine, Inc. and BioNTech SE, or browse the full rankings.